Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.

NEXT STORY
Oncternal Therapeutics Announced Pre-Clinical Data from ONCT-534, an Androgen Receptor N-Terminal-Domain-Binding Small Molecule Degrader, Was Accepted for Virtual Poster Presentation at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
PREV STORY
Gait Rehabilitation System Market Size to Outstrip $451.11Mn by 2028 Growth Projections at 5.8% CAGR During 2021 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Saniona AB: Saniona publishes its interim report for the second quarter 2017

PRESS RELEASE 23 August 2017 Financial highlights H1 2017 (H1 2016) ·         Net revenues were ...

author_avatar
NASDAQ Market News

OLYSIO® sales during the first quarter 2016

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the global first ...

author_avatar
NASDAQ Market News

Radius Health Announces Third Quarter 2018 Operating Results and Financial Guidance for FY 2018 and FY 2019

TYMLOS® U.S. net sales continued to increase in the third quarter of 2018, totaling ...

author_avatar
NASDAQ Market News